Project Details
Description
A Phase II/III, multicenter, partially randomized, open label trial investigating safety and efficacy of ondemand and prophylactic treatment with BAY 94-9027 in severe hemophilia A
| Status | Finished |
|---|---|
| Effective start/end date | 4/24/12 → 12/31/18 |
Funding
- BAYER HEALTHCARE PHARMACEUTICALS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.